LivsMed (491000.KQ) stock: key figures, P/E, revenue and dividend
Health Care · South Korea · ISIN KR7491000006
LivsMed financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 27.12 bn KRW | 51.19 bn KRW |
| Gross profit | 14.55 bn KRW | 29.53 bn KRW |
| Operating income | -26.50 bn KRW | -22.64 bn KRW |
| EBIT | -16.97 bn KRW | -22.05 bn KRW |
| Net income | -25.58 bn KRW | -22.87 bn KRW |
| Diluted EPS – continuing operations | -1,036.59 KRW | -926.74 KRW |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About LivsMed
Livsmed Inc. engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea. The company offers ArtiSential, a multi-joint articulating surgical instrument that is used for laparoscopic surgeries, as well as training kits. It exports to the Unites States, Germany, etc. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
More stocks
- Beijing Asiacom Information Technology Co.Ltd (301085.SZ)
- Hemnet Group AB (publ) (HEM.ST)
- Henan Hengxing Science & Technology Co Ltd (002132.SZ)
- Cancom (COK.DE)
- Winall Hi tech Seed (300087.SZ)
- Nuvectis Pharma, Inc. (NVCT)
- Yabao Pharmaceutical Group Co Ltd (600351.SS)
- Hellenic Exchanges Athens Stock Exchange SA (EXAE.AT)
- China Resources and Environment Co Ltd (600217.SS)
- Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096.SZ)
- Faraday Copper Corp (FDY.TO)
- JAFCO Group Co Ltd (8595.T)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.